pubmed-article:11298336 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1332717 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1706438 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1155065 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0085358 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1261478 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0947647 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1413244 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C2698600 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C0449774 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
pubmed-article:11298336 | lifeskim:mentions | umls-concept:C2348480 | lld:lifeskim |
pubmed-article:11298336 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:11298336 | pubmed:dateCreated | 2001-4-12 | lld:pubmed |
pubmed-article:11298336 | pubmed:abstractText | Therapeutic intervention with antiretroviral therapy (ART) enables the modulation of HIV virus load and hence provides a unique opportunity to study the consequences of varying antigen load on the phenotype of virus-specific CD8(+) T lymphocytes in a persistent human viral infection. The recent advent of tetrameric peptide / HLA class I complexes has enabled the direct phenotypic characterization of antigen-specific T cell populations ex vivo. Here, we use this technology to examine directly ex vivo the consequences of therapeutic manipulation of HIV virus load on the phenotype of HIV-specific CTL. Our observations show that: (1) distinct sequential activation patterns of CD8(+) T cells are associated with increasing virus load; (2) T cell receptor (TCR) down-regulation without apoptosis represents an early event during the generation of a T cell response in a natural infection and precedes the emergence of two distinct antigen-specific CD8(+) T cell populations which differ in TCR and CD8 expression levels. Clear differences in surface Annexin V staining were observed between these populations. The observation that CTL activation, demonstrated by TCR and CD8 down-regulation, in response to rising levels of virus load, co-segregates with apoptosis only during later stages of the response indicates that antigen-associated cell death is restricted to distinct subpopulations of CTL. | lld:pubmed |
pubmed-article:11298336 | pubmed:language | eng | lld:pubmed |
pubmed-article:11298336 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11298336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11298336 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11298336 | pubmed:month | Apr | lld:pubmed |
pubmed-article:11298336 | pubmed:issn | 0014-2980 | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:WeberJ NJN | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:CONER ARA | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:PriceD ADA | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:PhillipsR ERE | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:HirschelBB | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:FidlerSS | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:EasterbrookP... | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:OxeniusAA | lld:pubmed |
pubmed-article:11298336 | pubmed:author | pubmed-author:GünthardH FHF | lld:pubmed |
pubmed-article:11298336 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11298336 | pubmed:volume | 31 | lld:pubmed |
pubmed-article:11298336 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11298336 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11298336 | pubmed:pagination | 1115-21 | lld:pubmed |
pubmed-article:11298336 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:meshHeading | pubmed-meshheading:11298336... | lld:pubmed |
pubmed-article:11298336 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11298336 | pubmed:articleTitle | Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. | lld:pubmed |
pubmed-article:11298336 | pubmed:affiliation | Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, Great Britain. annette.oxenius@ndm.ox.ac.uk | lld:pubmed |
pubmed-article:11298336 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11298336 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11298336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11298336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11298336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11298336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11298336 | lld:pubmed |